Restart Life Sciences Corp. (CSE:HEAL)

Market Cap	3.97M
Revenue (ttm)	n/a
Net Income (ttm)	-562.53K
Shares Out	36.05M
EPS (ttm)	-0.03
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,029,000
Average Volume	163,645
Open	0.1000
Previous Close	0.1100
Day's Range	0.1000 - 0.1200
52-Week Range	0.0400 - 0.1750
Beta	-1.05
RSI	56.47
Earnings Date	Nov 27, 2025

About Restart Life Sciences

Restart Life Sciences Corp., through its subsidiaries, operates as a biotechnology company worldwide. It engages in developing natural remedies specifically tailored for individuals on the autism spectrum; health-related foods that promote both mind and body wellness for healthy living, as well as psilocybin clinical trial for fragile X syndrome. The company was formerly known as Nova Mentis Life Science Corp. and changed its name to Restart Life Sciences Corp. in November 2024. Restart Life Sciences Corp. was incorporated in 2004 and is based ...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2004
• Country: Canada
• Stock Exchange: Canadian Securities Exchange
• Ticker Symbol: HEAL